Other News To Note
Thursday, May 3, 2012
Mirna Therapeutics Inc., of Austin, Texas, reported data demonstrating that microRNA-34 (miR-34) mimics inhibited tumor growth in an animal model of B-cell lymphoma. The data, published in Leukemia, complemented those generated by Mirna and academic collaborators in animal models of lung and prostate cancer.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.